-
Signature
-
/s/ Michael A. Panzara
-
Stock symbol
-
WVE
-
Transactions as of
-
Jul 25, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
7/27/2022, 09:05 PM
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
WVE |
Share Option (right to buy) |
Award |
$0 |
+60K |
|
$0.00 |
60K |
Jul 25, 2022 |
Ordinary Shares |
60K |
$2.83 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Medical Officer, Head of Therapeutics Discovery and Development